
Prowell Pharmaceuticals Private Limited
About Prowell Pharmaceuticals Private Limited
Data last updated:
Prowell Pharmaceuticals Private Limited is a private limited company based in Kalol, Gujarat, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 16 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2019PTC106114. Its GSTIN is 09AAKCP3103A1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Praveen Kumar Mall and Mirza Ismail Baig.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Rajput Vinay Sigh Mahant Sigh Nr. Radheshyam Bakery, Kalol, Gujarat, India – 382721.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.71 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net loss of ₹46,272 (net margin -4%) and EBITDA of -₹31,379 (EBITDA margin -2.7%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 36% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Prowell Pharmaceuticals Private Limited's registered office is in Kalol, Gujarat. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Rajput Vinay Sigh Mahant Sigh Nr. Radheshyam Bakery, Kalol, Gujarat, India – 382721
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Prowell Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Prowell Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Prowell Pharmaceuticals Private Limited, buy the company report.
Financials of Prowell Pharmaceuticals Private Limited
FY 2025 filings availableProwell Pharmaceuticals Private Limited reported revenue of ₹11.71 Lakh (down 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 36%. EBITDA fell 444% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹31,379 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹46,272 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.7% | ||||
| Net Profit Margin | -4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Prowell Pharmaceuticals Private Limited, buy the company report.
Board of directors of Prowell Pharmaceuticals Private Limited
Prowell Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praveen Kumar Mall | Director | 16 Jan 2019 | 7 Years 10 Months | Current |
| Mirza Ismail Baig | Director | 01 Aug 2023 | 3 Years 3 Months | Current |
Peer comparison
Prowell Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chairo Pharmaceuticals Private Limited | ₹11.71 Lakh (FY 2025) | 56.0% | Pune, Maharashtra, India | |||
| Prowell Pharmaceuticals Private Limitedthis company | ₹11.71 Lakh (FY 2024) | -₹46,272 | -4% | -6.0% | Kalol, Gujarat, India | |
| Newzen Pharmaceuticals Private Limited | ₹11.7 Lakh (FY 2020) | -38.0% | Delhi, India | |||
| Western Indian Pharmaceuticals (OPC) Private Limited | ₹11.69 Lakh (FY 2025) | -8.0% | Indore, Madhya Pradesh, India | |||
| Finlo Pharmaceuticals Private Limited | ₹11.68 Lakh (FY 2021) | Guwahati, Assam, India | ||||
| Confiance Pharmaceuticals Private Limited | ₹11.67 Lakh (FY 2025) | -15.0% | Madhubani, Bihar, India |
To see the full peer comparison of Prowell Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Prowell Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prowell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Prowell Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCP3103A1ZX | Uttar Pradesh | Active | 30 Jan 2019 |
To see the full GST registrations and return filing status of Prowell Pharmaceuticals Private Limited, buy the company report.
Recent activity
Prowell Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Mani Pratap Chand ceased to be Additional Director on 02 Aug 2023.
Frequently asked questions
Prowell Pharmaceuticals is an active private limited company based in Kalol, Gujarat, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 16 January 2019 (7+ years old) and is registered under CIN U24230GJ2019PTC106114.
Prowell Pharmaceuticals has 2 current directors:
- Praveen Kumar Mall - Director
- Mirza Ismail Baig - Director
The latest financial statements of Prowell Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Prowell Pharmaceuticals is 09AAKCP3103A1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Prowell Pharmaceuticals is U24230GJ2019PTC106114. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prowell Pharmaceuticals was incorporated on 16 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Prowell Pharmaceuticals by revenue are Chairo Pharmaceuticals Private Limited, Newzen Pharmaceuticals Private Limited, Western Indian Pharmaceuticals (OPC) Private Limited, Finlo Pharmaceuticals Private Limited, Confiance Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Mani Pratap Chand ceased to be Additional Director on 02 Aug 2023. Mirza Ismail Baig was appointed as Director on 01 Aug 2023. Anil Kumar Mall ceased to be Director on 30 Jan 2019. Prowell Pharmaceuticals has 4 board changes on record in total.
The registered office of Prowell Pharmaceuticals is at CO Rajput Vinay Sigh Mahant Sigh Nr. Radheshyam Bakery, Kalol, Gujarat, India – 382721.
Prowell Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Prowell Pharmaceuticals is compliant as of 26 August 2026. The company is actively filing with the Registrar of Companies.

